Close

Eisai, Arena Pharma (ARNA) Announce FDA Approval of BELVIQ XR ER; Arena to Receive $10M Milestone Payment

July 19, 2016 8:30 AM EDT Send to a Friend
Eisai Inc. and Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) today announced that the U.S. Food and Drug Administration (FDA) has approved ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login